R158Q and G212S, novel pathogenic compound heterozygous variants in SLC12A3 of Gitelman syndrome

{{article.zuoZheEn}}

PDF(4725 KB)
PDF(4725 KB)
Front. Med. ›› 2022, Vol. 16 ›› Issue (6) : 932-945. DOI: 10.1007/s11684-022-0963-9
RESEARCH ARTICLE

R158Q and G212S, novel pathogenic compound heterozygous variants in SLC12A3 of Gitelman syndrome

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2022, 16(6): 932‒945 https://doi.org/10.1007/s11684-022-0963-9

References

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
Share on Mendeley
PDF(4725 KB)

Accesses

Citations

Detail

Sections
Recommended

/